Client & Alumni News

OraSure says rapid COVID-19 test should be ready by 4Q

POSTED ON Thursday, August 6th, 2020 IN CLIENT & ALUMNI NEWS

Ben Franklin client, OraSure Technologies, expects to launch its COVID-19 rapid antigen in-home self-test by the fourth quarter of this year. The test is being built on the same OraQuick platform that the company has used to create similar tests for HIV and Hepatitis C.

The OraQuick Coronavirus Rapid Antigen Self-Test is a potential game-changer, said Steven Tang, president and CEO of OraSure. The at-home test quickly detects active COVID-19 infection at the point of sample collection with no instrumentation needed to interpret results, and no need to transport samples to a lab for analysis. Users swab their lower nostril to collect the sample and read their results a short time later.

Tang said OraSure’s COVID-19 antigen self-test could become a valuable tool for opening up economies, keeping them open, and enabling the safe return to work, school,and group events. Via Lehigh Valley Business

SHARE THIS POST

The Ben Franklin Technology Partners is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.